RTCure retweeted
🤔If #arthritis was detected earlier, could it be prevented? The @RTCure_eu project sought to understand just that! Join us on 5 June at 11:00 for 'In conversation with RT Cure' where we'll find out about their work on #ArthritisResearch. Register here: europa.eu/!bxTW9M
RTCure retweeted
Preferences for preventive treatments for #rheumatoidarthritis: discrete choice survey in the UK, Germany and Romania 👇
doi.org/10.1093/rheumatology…
RTCure retweeted
We are pleased to invite you to the 5th Digital rheumatology day. Register today!
digitalrheumatology.org/5th-…
RTCure retweeted
NEW PAPER: What risk of side effects is acceptable for a reduced risk of developing rheumatoid arthritis? Informing patient-focussed drug development
rmdopen.bmj.com/cgi/content/…
@IMI_PREFER @RRG_Birmingham @InflamAge_UoB @NIHRBhamBRC @BHPComms @unibirm_MDS
RTCure retweeted
Apply now for the "Digital Rheumatology Research Award"!
Please find further information on how to apply here:
lnkd.in/eG8em44b
#RheumaAward #DigitalRheumatology
RTCure retweeted
🔔State-of-the-Art Keynote Speaker
Meet Dr. @ProfJohnIsaacs, our State-of-the-Art keynote speaker at the 2023 Annual Scientific Meeting!
He will be delivering a keynote presentation on Precision Medicine in Rheumatoid Arthritis.
Register today🔗asm.rheum.ca
RTCure retweeted
Our latest paper on patient and public involvement (#PPI) in @RTCure_eu. #rheumatology bmcrheumatol.biomedcentral.c…
RTCure retweeted
@ArthritisDigest @Arthritisie @VersusArthritis @K_Betteridge @Neil_Betteridge @Kouloumasm @xico_nunes @humanaic @NRAS_UK @SjogrenEurope @RTCure_eu @orf_at @H12R12 @ArthritisDay @RA_information @DtRheumaLiga @puls4
RTCure retweeted
JUST PUBLISHED: Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis by G Simons, K Schölin Bywall, M Englbrecht, EC Johansson, RL Disantostefano, C Radawski @JorienVeldwijk K Raza & @DrMarieFalahee 👇
tandfonline.com/doi/full/10.…
RTCure retweeted
Interesting genetic analysis by Rachel Knevel on drug-free remission from @RTCure_eu #TTW2022 A smoking gun analysis implicates the fibroblast?
RTCure retweeted
Great Pleasure to present my PhD project to partners from industry & academia @RTCure_eu Annual Meeting 2022 in Amsterdam.
RTCure retweeted
Great presentations this afternoon on early trials in ACPA positive and the progression to RA @MRGNewcastle @Racegbn @RTCure_eu
RTCure retweeted
A landmark paper. RA-MAP Scientific Data - the most complete immunological profile in early rheumatoid arthritis to date
@RTCure_eu @Racegbn @ProfJohnIsaacs @thebarneslab @imidbio
nature.com/articles/s41597-0…
RTCure retweeted
Accelerating diagnosis in #rheumatology using #ehealth📲🚀😀 Great #teamwork @ArndKlyr @Dr_David_Simon led by @RachelKnevel supported by @EITHealth frontiersin.org/articles/10.… @digital_rheuma @medizin_digital
RTCure retweeted
Want to know more about quantitative preference studies of treatments for #RheumatoidArthritis among #patients and at-risk populations? @IMI_PREFER published a #SystematicReview!
#RA @reumatiker @R2P2_UoB @InflamAge_UoB 👇
bit.ly/3F3InIC
RTCure retweeted
At #BSR22 3pm you may like to attend the 'Prediction and prevention of rheumatoid arthritis: an update' session chaired by RACE's Karim Raza with talks from John Isaacs and Marie Falahee amongst others (venue Boisdale) @ProfJohnIsaacs @DrMarieFalahee @MRGNewcastle @RRG_Birmingham
RTCure retweeted
Increasingly more programs for individuals #at-risk for #rheumatoid #arthritis exist across Europe. With @RTCure_eu we have built the framework for researching together by setting up the #European Risk RA registry
tinyurl.com/2n3nc88e
🎞️a summary: bpno.dk/gp/MjA2MTThg_Bgp0A
RTCure retweeted
Join our event either virtually or on site in Berlin from May 6-7 and explore the future in Rheumatology! Register today: digitalrheumatology.org/4th-… #DigitalRheumatologyDay @LatikaGupta_ @JK77775 @KruscheMartin @ThomasHugle @Dr_David_Simon
RTCure retweeted
Replying to @RTCure_eu
@RTCure_eu @Racegbn Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis pubmed.ncbi.nlm.nih.gov/3497…
RTCure retweeted
JUST PUBLISHED! A systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations!
doi.org/10.1186/s13075-021-0…
@ArthritisRes
What aspects of treatments to prevent RA matter most to those at risk? More studies of people's preferences are needed to guide the development of acceptable interventions! @IMI_PREFER @RRG_Birmingham @NIHRBhamBRC @BHPComms @Racegbn
rdcu.be/cHyQE



















